Alternatives to Early Labs

Developing novel diagnostics to predict patient response to immunotherapy.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Develops toilet-integrated diagnostic technology for early health condition detection.

AI-powered blood test for early cancer detection and subtyping.

AI-powered spatial biology platform for precision medicine and drug development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Personalized diagnostics for cancer genomic markers at the point of treatment.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Harnessing genetic data for digital insights in rare and germline disorders.

AI-powered vocal biomarkers for health screening, detection, monitoring, and prediction.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children.

AI-driven platform for faster and more efficient diagnosis of women's health issues.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Passive optical sensor for real-time health alerts and disease progression monitoring.

ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Uses smartphone technology to objectively measure eye movements for brain health assessment.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

Digital physical therapy and recovery platform using everyday sensors for ongoing health diagnostics.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Transforms smartphone cameras into medical devices for home urinalysis and digitized wound care.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Pentaomix develops a breakthrough biopsy imaging modality for unprecedented accuracy in pathology analysis.

AI-powered platform personalizing and optimizing cancer patient monitoring and treatment.

Bioelectric medicine company advancing neurorecovery for stroke and neurological conditions.

Clinical reasoning AI engine for scalable, high-value healthcare intake and assessment.

Belong.Life creates social and professional networks for patients and healthcare professionals to manage and navigate various diseases and patient journeys.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing CORA, a smart exam for early detection of coronary artery disease.

Developing advanced magnetic resonance imaging (MRI) technology for enhanced medical diagnostics.

MDacne is a mobile app that uses AI-powered computer vision for real-time acne analysis and provides personalized treatment.

Global network of clinics using AI and data science to treat age-related cognitive and functional decline.

Clair Labs develops medical-grade, contact-free vital signs sensing technology powered by deep learning and computer vision for proactive healthcare.

AI-powered platform to enhance fertility treatment success rates and patient experience.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Nevia Bio is a femtech startup focused on early detection of women's health conditions.

A platform for functional, integrative, and longevity medicine.

TechsoMed develops ultrasound-based real-time monitoring systems for thermal ablation procedures, enhancing safety and efficacy.